CHICAGO TRUST Co NA cut its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 6.7% in the 4th quarter, Holdings Channel reports. The fund owned 5,582 shares of the company’s stock after selling 400 shares during the period. CHICAGO TRUST Co NA’s holdings in Colgate-Palmolive were worth $507,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of CL. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the 3rd quarter worth about $42,000. Capital Performance Advisors LLP bought a new stake in Colgate-Palmolive in the third quarter valued at about $53,000. Prospera Private Wealth LLC bought a new position in Colgate-Palmolive during the 3rd quarter worth approximately $64,000. True Wealth Design LLC grew its position in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after acquiring an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC raised its position in shares of Colgate-Palmolive by 93.4% during the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock valued at $79,000 after acquiring an additional 368 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.
Analysts Set New Price Targets
Several analysts have weighed in on CL shares. Stifel Nicolaus lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their target price for the company from $105.00 to $101.00 in a research note on Monday, October 28th. TD Cowen dropped their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Finally, Piper Sandler lowered their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and a consensus price target of $103.63.
Insider Activity at Colgate-Palmolive
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.34% of the stock is owned by company insiders.
Colgate-Palmolive Trading Up 0.8 %
Shares of NYSE:CL opened at $87.02 on Tuesday. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The stock has a market capitalization of $71.10 billion, a PE ratio of 24.93, a P/E/G ratio of 3.31 and a beta of 0.44. Colgate-Palmolive has a 1 year low of $79.69 and a 1 year high of $109.30. The firm has a fifty day moving average price of $92.49 and a 200 day moving average price of $97.98.
Colgate-Palmolive Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.30%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 57.31%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- What is a Secondary Public Offering? What Investors Need to Know
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Canadian Penny Stocks: Can They Make You Rich?
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- How to Invest in the FAANG Stocks
- Delta Can Fly to New Highs in 2025; Here’s Why
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.